Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Intermediate DEND syndrome (iDEND) is a rare mild form of DEND syndrome, a neonatal diabetes mellitus, developmental delay and epilepsy condition. The intermediate form is characterized clinically by mild motor, speech or cognitive delay and an absence of epilepsy.
Estimated prevalence: Unknown (Unknown prevalence).
No clinical trials have been registered for intermediate DEND syndrome.
4 publications have been identified in PubMed for intermediate DEND syndrome. Research spans Review / Meta-Analysis (50%), Case Report / Case Series (25%), and Basic Science / Preclinical (25%).
Plengvidhya N (2026). [PMID: 41498801](https://pubmed.ncbi.nlm.nih.gov/41498801/). *Hum Genet*. [Basic Science / Preclinical]
Abreu GM (2025). [PMID: 41169283](https://pubmed.ncbi.nlm.nih.gov/41169283/). *Front Clin Diabetes Healthc*. [Case Report / Case Series]
Saadati S (2025). [PMID: 41376626](https://pubmed.ncbi.nlm.nih.gov/41376626/). *Front Immunol*. [Review / Meta-Analysis]
Gobble MRS (2025). [PMID: 40128490](https://pubmed.ncbi.nlm.nih.gov/40128490/). *Curr Diab Rep*. [Review / Meta-Analysis]
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 2:11 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center